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Antimicrobial resistance is threatening humans and animals worldwide. Biosecurity and 1-year usage of
antibiotics on a dairy concentrated animal feeding operation (CAFO) in NY State, USA, were mapped: how
much antibiotics were used, for what purpose, and whether any decrease could be warranted. Approximately
493 kg antibiotics was used, of which 376 kg was ionophores (monensin and lasalocides), 79 kg penicillin,
16.5 kg lincosamides, 8.0 kg aminoglycosides, 7.7 kg sulfamides, 3.4 kg cephalosporin, 2 kg macrolides, 0.7 kg
amphenicols, and 0.1 kg fluoroquinolones. Usage reduction by 84% was realistic without compromising the
animal welfare. Further reduction could be possible by improving the biosecurity and by utilizing antibiotic
sensitivity testing.
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I
t is estimated that every year 23,000 people die and 2
million people get sick from infections caused by
antibiotic-resistant microbes in the USA (1). The
world is approaching the post-antibiotic era, and to slow
down progression, antibiotic stewardship as well as preven-
tion strategies are necessary (1). In the yearly global risk
report by the World Economic Forum 2013, antibiotic-
resistant bacteria were identified as one of the top global
societal risks facing mankind (2). The single most im-
portant factor in developing antibiotic resistance is usage;
the more antibiotics are used, the more resistance inevitably
develops. There is also a clear link between antibiotic use
on the farm, antibiotic resistance, and human antibiotic
treatment failure (1, 3).
In 2010, the US Department of Agriculture (USDA)
started to require antibiotic manufacturers to report their
sales in the USA (4), while in Sweden, by comparison,
information has been collected since the 1980s (5). Very
little data exist on how much antimicrobials are used on
actual farms in the USA. Without detailed information
of antimicrobial usage in agriculture, measurements to
curtail the usage are unfeasible.
The objective of this study was to map the actual usage
of antibiotics on a dairy concentrated animal feeding
operation(CAFO)inNYStateduring2013.Theintention
was to evaluate how much antibiotics were used, for
what purpose, and to establish whether any decrease in
antimicrobial usage could be warranted. Biosecurity was
also investigated. The findings will be used for further
studies in site-specific antibiotic resistance patterns, and
the impact the antibiotic usage could have on the environ-
ment in connection to the CAFO.
Material and methods
The studied dairy CAFO milks 2,000 and has close
to a total of 4,000 animals, separated into two different
locations. The milk production is approximately 12,000 kg
per 305 day lactation. The dairy has expanded, with the
herd size doubling several times during the last decade.
A substantial number of new animals were introduced
into the herd during the 10% herd expansion throughout
2013. The owner provided access to all the purchased
receipts through 2013. The antibiotic purchases were
cataloged in grams of active substance using Microsoft
Excel and organized into different classes of antibiotics.
The different feed rations were utilized to calculate the
ionophore (monensin and lasalocides) usage. The milk
testing results (the tests are performed four times per
year) were used to approximate a possible decrease in dry
cow treatment. The dairy management was interviewed
with a biosecurity survey developed by Moore (6),
consisting of 43 questions to evaluate the risks associated
with biosecurity.
infection ecology &
epidemiology
The One Health Journal

Infection Ecology and Epidemiology 2014. #2014 Marie Doane and Sirkku Sarenbo.ThisisanOpenAccessarticledistributedunderthetermsoftheCreative
Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and
reproduction in any medium, provided the original work is properly cited.
1
Citation: Infection Ecology and Epidemiology 2014, 4: 24259 - http://dx.doi.org/10.3402/iee.v4.24259
(page number not for citation purpose)Results and discussion
In 2013, the dairy used approximately 493 kg antibiotics
which were divided into: 376 kg ionophores (monensin
and lasalocides), 79 kg penicillin, 16.5 kg lincosamide,
8 kg aminoglycosides, 7.7 kg sulfamides, 3.4 kg cephalos-
porin, 2 kg macrolides, 0.7 kg amphenicols, and 0.1 kg
fluoroquinolones (Table 1).
All consumed antibiotics with the exception of the
ionophores are classified according to WHO (3) as very
important or critically important to human medicine. The
cephalosporin usage at the dairy CAFO was 3.4 kg, in
stark contrast to the entire Swedish cattle (0.5 million
heads) usage of 7.0 kg in 2012 (5). In Sweden, cephalos-
porins are only permitted for animal use when all other
treatment options have been exhausted and cephalospor-
insaretestedeffective(5).IntheUSA,anew2012directive
restricts the use of cephalosporin drugs outside of
approved use, in so-called extra label use (7). Swedish
cattle used a total 4.02 kg of macrolides and lincosamides
in2012, while thedairy CAFO used 18.5 kgin2013. While
the farm does fairly extensive pathogen testing, very
little or no testing is done to ensure correct effective
antibiotic usage, which is reflected in the variation in anti-
biotics used for bovine respiratory disease (BRD). The
management’s perception is that this type of testing does
not exist or that it lacks the timelines required for effective
treatment.
Most of the antibiotics (excluding ionophores), 73.8 kg,
were used by the milking cows: 24.6 kg by calves and
19 kg by heifers. The most common bacterial diseases on
this dairy are mastitis and BRD; both multifactorial and
often multi-bacterial (8), making diagnosis and treatment
difficult. Other common disorders are general infections
and hoof disorders, while others are metabolic such as
metritis, ketosis, and calf diarrhea. The route of admini-
stration can be summarized as 78% oral, 11% injectable,
10% intramammary, and 1% topical.
Allanimalsarefedionophoresbecausetheyimprovethe
milk production efficiency without compromising the
body condition of the cows (9), while ionophores can treat
ketosis (10). The US authorities have decided to phase out
antibiotics feed as growth promotion; unfortunately, it
only includes antibiotics deemed important today to
human medicine (11). In comparison, antimicrobial usage
on growth promotion was banned in 1986 in Sweden (5).
Ionophores, while not used at present in human medicine,
are showing some promise of becoming a cancer therapy
(12). The US Food and Drug Administration (FDA) is
investigatingthepossiblelinkbetweenionophore-resistant
and simultaneously acid-resistant Escherichia coli with the
potential of serious human illness (13). To decrease the
antimicrobial usage today, all antibiotics used as a feed
additive could be excluded, which would result in a 76%
reduction. The next area where antibiotic usage could
decline today is in mastitis treatment.
Alllactatingcowsweregivendrytreatmentattheendof
the lactation per recommended praxis in the USA (14).
However, selective dry cow treatment could be utilized
without endangering animal welfare or production (15,
16). On average, 71% of the lactating cows displayed
somaticcellcounts (SCC),measured by milktesting, ofless
than 142,000 SCC. For this study, we assumed that a 25%
probability of all cows with a tested SCC B142,000 are
having a mastitis at dry off, based on udder health classes
usedinSweden(17).Thecows(29%)withanSCC  142,000
are automatically given dry cow treatment. Cows with
Table 1. Antibiotic use at a large dairy in NY State, USA
Class of
antimicrobials
Amount (kg) used for
Importance to human
medicine (3) Cows Heifers Calves Used as Treating
Cephalosporin 3.4 0 0 Treatment 96%
prophylactic 4%
BRD, metritis, dry cow
treatment
Highly important 8%
Critically important 91%
Penicillin 61 18 0 Treatment 79%
prophylactic 21%
Dry cow treatment, local
infections, mastitis
Critically important 100%
Ionophores 268 78 30 Feed efficiency 100% Coccidiosis, ketosis At the present not used in
human medicine
Lincosamide 1.1 0 15.3 Treatment 22%
prophylactic 78%
Mastitis, BRD, feet infections Highly important 100%
Amphenicols 0 0 0.7 Treatment 100% BRD Highly important 100%
Macrolides 0.3 1 0.8 Treatment 100% BRD, foot rot Critically important 100%
Fluoroquinolones 0 0 0.1 Treatment 100% BRD Critically important 100%
Sulfamides 0 0 7.7 Treatment 100% Calf diarrhea Highly important 100%
Aminoglycosides 8 0 0 Treatment 67%
prophylactic 33%
Dry cow treatment, feet Critically important 100%
Total used (kg) 341.8 97 54.6 All antibiotics 493.4
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with a ‘cow side’ test, using a testing method and device
(18)suitablefortheindividualfarm’spreferences.Withour
assumptionof25%infections,25%ofthesecowswithSCC
B142,000 still need to be dry cow treated. Using selective
dry cow treatment could, with our assumption and this
dairy CAFO’s average SCC, lead to a 47% reduction in
antibiotic usage due to dry cow treatment.
During 2013, the herd had a calf respiratory outbreak
of Mycoplasma bovis, and a limited prophylactic group
treatment of lincosamide was administered. Excluding
the use of ionophore, using selective dry cow treatment
and no prophylactic use of antimicrobials could, in
theory, have decreased the antibiotic usage in 2013 from
493 to 81 kg, a decrease of 84% without compromising
animal welfare.
In Sweden, there has been a steady decline in antibiotic
use in farm animals since the 1980s, showing that a
decrease in the use of antibiotics is realistic with the right
guidelines and rules (5). The antibiotic usage in the
present US dairy should be initiated with antibiotic
sensitivity testing, starting all treatment with narrow-
spectrum antibiotics and only using broad-spectrum anti-
biotics, when proven effective and the narrow-spectrum
antibiotics fail. In an outbreak, sensitivity testing should
be repeated at least every 6 months.
One of the best options to decrease antibiotic usage is
to prevent the infection in the first place with improved
biosecurity (1). The biosecurity survey raised questions
in the area of cattle purchases and livestock movement,
reducing transmission onto the farm and within the
farm (6). Certain disease testing was done before animal
purchase; however, quarantine is never utilized when the
animals enter the farm. Very few hygiene routines are in
place to minimize the risk of transmission of microbes
onto the farm, such as visitors and farm employees
wearing clean clothing, coveralls, and clean footwear.
The calving pen and barn are only used for calving and
calves are separated from the dam and fed single-source,
high-quality, tested colostrums in a timely manner. The
dairy CAFO has excellent pest management and milking
hygiene practices, but quarantine of sick animals is not
utilized. Sick milking cows are only moved from their
designated group if they are too sick to function properly
or if they need antibiotic treatment, while the heifers and
calves almost always stay in the herd. Improvements in
biosecurity would require a renewal of management
strategies.
In conclusion, approximately 493 kg of antibiotics was
used in 2013 at the dairy CAFO. Antibiotic usage re-
duction by 84% was found realistic without compromis-
ing the animal welfare. With improvements in biosecurity
and antibiotic sensitivity testing to ensure appropriate
and effective usage, the antimicrobial use could decrease
even further.
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